FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30319211000001108: Palivizumab 50mg/0.5ml solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94014101000001114 Palivizumab 50mg/0.5ml solution for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94014201000001119 Palivizumab 50mg/0.5ml solution for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palivizumab 50mg/0.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intramuscular route true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.intramuscular ontology form and route true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Is a Palivizumab true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Plays role Passive immunity stimulant therapeutic role true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Is a Product containing palivizumab false Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has active ingredient Palivizumab false Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has specific active ingredient Palivizumab true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Is a True Palivizumab 50mg/0.5ml solution for injection vials Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials 1 vial Has VMP True Palivizumab 50mg/0.5ml solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start